Skip to main content

Advertisement

Log in

A Prospective Study of Gastric Acid Analysis and Esophageal Acid Exposure in Patients with Gastroesophageal Reflux Refractory to Medical Therapy

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

A number of factors have been proposed to account for the lack of response to medical therapy in patients with gastroesophageal reflux; however, no controlled studies are available in the literature. The goal of this study was to determine possible causes of medical refractoriness in patients with gastroesophageal reflux. Gastric acid output and esophageal acid exposure were measured in patients who continue to have reflux symptoms despite aggressive antisecretory therapy. In addition, an upper endoscopy was also performed in each patient. Patients with a drug-controlled acid output < 1 mEq/hr and a supine total esophageal pH < 4 for less than 1.7% of the time measured were considered responsive to therapy; on the other hand, those with a drug-controlled gastric acid output > 1 mEq/hr and a supine esophageal pH < 4 for more than 1.7% of the time measured were considered resistant to therapy. Twenty -four patients met the inclusion criteria (13 male and 11 female; mean age, 52). Drug-controlled gastric acid output was more than 1 mEq/hr in 25% of patients and less than 1 mEq/hr in the remainder. Of those patients with a gastric acid output of less than 1 mEq/hr (18 patients), 8(44%) had a supine esophageal pH < 4 for more than 1.7% of the time, suggesting that factors other than gastroesophageal reflux likely contributed to their reflux-like symptoms. Acid suppression appears adequate in the majority of patients with gastroesophageal reflux refractory to medical therapy. The exact cause of persistent reflux-like symptoms in patients who fail medical treatment is uncertain but may be related to non-acid-related factors such as esophageal hypersensitivity to physiologic reflux, increased intake of air resulting in aerophagia, or other factors such as bile reflux.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. An evidence based appraisal of reflux disease management the Geneva Workshop Report. Gut 44(2):S1–S16, 1999

  2. Leite LP, Johnston BT, Just RJ, Castell DO: Persistent acid secretion during ompeprazole therapy: A study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 91:1527–1531, 1996

    PubMed  Google Scholar 

  3. Collen MJ, Lewis JH, Benjamin SB: Gastric acid hypersecretion in refractory gastroesophageal disease. Gastroenterology 98:654–661, 1990

    PubMed  Google Scholar 

  4. Pandolfino JE: Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 98:740–749, 2003

    Article  PubMed  Google Scholar 

  5. Knuff TE, Benjamin SB, Worsham F, et al.: Histologic evaluation of chronic gastroesophageal reflux. An evaluation of biopsy methods and diagnostic criteria. Dig Dis Sci 29:194–201, 1984

    Article  PubMed  Google Scholar 

  6. Clouse RE, Richter JE, Heading RC, Janssens J, Wilson JA: Functional esophageal disorders. Gut 45 (Suppl II):II31–II36, 1999

    PubMed  Google Scholar 

  7. Cannon RO, Benjamin SB: Chest pain as a consequence of abnormal visceral nociception. Dig Dis Sci 38(2):193–196, 1993

    Article  PubMed  Google Scholar 

  8. Attwood SEA, Ball CS, Barlow AP, et al.: Role of intragastric and intraesophageal alkalinization in the genesis of complications in Barrett's columnar lined lower esophagus. Gut 34:11–15, 1993

    PubMed  Google Scholar 

  9. Champion G, Richter JE, Vaezi MF, et al.: Duodenogastroesophageal refux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 107:747–754, 1994

    PubMed  Google Scholar 

  10. Drossman DA: Importance of the psyche in heartburn and dyspepsia. Aliment Pharmacol Ther 11 (Suppl 2):57–67, 1997

    PubMed  Google Scholar 

  11. Clouse RE, Lustman PJ, Eckert TC, Ferney DM, Griffith LS: Low dose trazodone for symptomatic patients with esophageal contraction abnormalities: double blind placebo controlled trial. Gastroenterology 92:1027–1036, 1986

    Google Scholar 

  12. Foud YM, Katz PO, Castell DO: Patients with refractory nocturnal gastroesophageal reflux have more prevalent esophageal motility abnormalities. Am J Gastroenterol 93:1615, 1998

    Google Scholar 

  13. Kauer WKH, Peters JH, DeMeester TR, et al.: Mixed reflux of gastric and duodenal juice is more harmful to the esophagus than gastric juice alone. Ann Surg 222:525–533, 1995

    PubMed  Google Scholar 

  14. Vela M, Camacho-Lobato L, Hatlebakk J, et al.: Effect of omeprazole on ratio of acid to nonacid gastroesophageal reflux: Studies using simultaneous intraesophageal impedance and pH measurement. Gastroenterology 116:G0910, 1999

    Google Scholar 

  15. Kamolz T: Comorbidity of aerophagia in GERD patients:outcome of laparoscopic antireflux surgery. Scand J Gastroenterol 37(2):138–143, 2002

    Article  PubMed  Google Scholar 

  16. Hirschowitz BI: A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 101:1149–1158, 1991

    PubMed  Google Scholar 

  17. Sagar M, Seensalu R, Tybring G, et al.: CYP2C19 genotype and pheotype determined with omeprazole in patients with acid-related disorders with and without Helicobacter pylori infection. Scand J Gastroenterol 33:1034–1038, 1998

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahlawat, S.K., Mohi-Ud-Din, R., Williams, D.C. et al. A Prospective Study of Gastric Acid Analysis and Esophageal Acid Exposure in Patients with Gastroesophageal Reflux Refractory to Medical Therapy. Dig Dis Sci 50, 2019–2024 (2005). https://doi.org/10.1007/s10620-005-3001-2

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-3001-2

Keywords

Navigation